Chlamydia Screening for Women
MIPS High Priority Measure:
Eligible for Quality Programs:
Percentage of women 16-24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement period.
- Numerator: Women with at least one chlamydia test during the measurement period.
- Denominator: Women 16 to 20 and 20 to 24 years of age who are sexually active and who had an eligible visit (defined as chart notes with one of the following encounter types: Office Visit, Nursing Home Visit, Nurse Visit or Home Visit) during the measurement period.
Denominator Exclusions: Women who are only eligible for the initial population due to a pregnancy test and who had an x-ray or an order for a specified medication within 7 days of the pregnancy test.
Denominator Exceptions: None
Practice Fusion Suggested Workflow
Practice Fusion suggests the following workflow to help ensure that you are able to meet the requirements of this measure within the Practice Fusion EHR.
For all visits with female patients age 16-24 years of age, determine if she is sexually active as defined by the measure and ensure the correct data identifying her as such is entered in the medical record.
Examples of diagnosis codes and lab tests that identify sexually active patients can be found in Table 1.
For female patients who are deemed to be sexually active as defined by the measure, ensure that she has received a chlamydia test during the measurement period or ensure that a chlamydia test is completed.
Once the chlamydia test is completed, receive or record structured lab results for Pap Smear or Chlamydia Screening tests in the Practice Fusion EHR.
Table 1: Examples of Coded Values that can be recorded for CMS 153v5
Diagnosis Codes that identify Sexually Active Patients
Lab Tests that identify Sexually Active Patients
Procedures that identify Sexually Active Patients
Medication Orders that identify Sexually Active Patients
Pap Smear Test Codes
Chlamydia Screening Test Codes
Additional Measure Information
This 2016 measure version has been updated from the previous 2015 version specifications, incorporating the following change:
Clarified the description of the denominator exclusions.
Added a sentence in the guidance to clarify who was eligible for the denominator exclusion.
Added logic to match the guidance for the denominator exclusion.
To be recognized for the denominator exclusion, the patient must have the appropriate diagnosis code, X-ray, or medication order recorded in her chart. Women who receive a pregnancy test solely as a safety precaution before ordering an X-ray or specified medications are also excluded from this measure. Please ensure that the pregnancy test and the associated x-ray are recorded in the patient chart if a patient should be excluded.
Please note that the denominator exclusion does not apply to patients who qualify for the denominator based on services other than the pregnancy test alone. These other services include services for sexually transmitted infections, contraceptives or contraceptive devices and infertility treatments.
- For more information on the CMS specifications for this measure, please click here.
- To learn more about MIPS quality measure reporting requirements for 2017, visit What are the Quality measure reporting requirements for MIPS?
- For additional information about quality measures, you may also visit the CMS Quality Payment Programs website and Practice Fusion’s Quality Payment Program Center.